Treatment	Cause	Edge Weight	Shared Publications
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 14: Psychological Stress and Neuroinflammatory Pathways in COPD Exacerbation and Progression	0.07734806629834254	14
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 35: Cardiovascular and Metabolic Comorbidities as Modifiable Risk Factors for COPD Exacerbation	0.07112068965517242	33
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 18: Unraveling the Molecular Interplay of β Adrenoceptors, Gasotransmitters, and Sulfonation in COPD Pathogenesis	0.06958250497017893	35
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 8: Estrogen-Regulated Autophagy and miRNA Networks in Endometriosis-Related COPD Pathogenesis	0.038535645472061654	20
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 2: Interplay between Occupational Hazards and Respiratory Mechanics in COPD Pathophysiology	0.024128686327077747	9
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 19: Adipose Tissue Inflammation and Metabolic Dysfunction in the Pathogenesis of COPD	0.022727272727272728	7
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 31: Cardiac Dysfunction and Inflammation: A Novel Link to COPD Pathogenesis and Comorbidity	0.0223463687150838	8
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 27: Neuroinflammatory Pathways in COPD Development: Shared Mechanisms with Neurodegenerative Conditions	0.01991150442477876	9
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 32: Autoimmune and Autoinflammatory Conditions as Indicators of COPD Risk and Disease Progression	0.015015015015015015	10
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 30: Modulating Bronchial Inflammation in Cystic Fibrosis-Related COPD: Environmental, Genetic, and Therapeutic Interactions	0.011695906432748537	6
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 25: Wound Healing Dysregulation and Tissue Remodeling as Systemic Influencers of COPD Pathogenesis	0.006944444444444444	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 39: Renal Dysfunction and Inflammation as Critical Modulators of COPD Pathogenesis and Exacerbation Risk	0.006230529595015576	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 17: Eicosanoid Dysregulation and Cox Inhibition: Unveiling the Complex Links between COPD and Cardiovascular, Gastrointestinal, and Metabolic Disorders	0.006134969325153374	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 26: Epigenetic and Inflammatory Regulation of Oxidative Stress and Nitric Oxide Production in COPD Pathogenesis	0.0061162079510703364	4
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 4: NLRP3 Inflammasome-Mediated Inflammatory Dysregulation in COPD Pathogenesis and Therapeutic Targets	0.005376344086021506	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 23: Hormetic Regulation of Oxidative Stress and Inflammatory Pathways in COPD and Related Ischemic Diseases	0.004694835680751174	3
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 12: Viral-Induced Hypercoagulability and Inflammatory Pathways to COPD Exacerbation and Tissue Damage	0.004464285714285714	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 16: Unveiling Novel Targets and Immune Mechanisms in COPD Pathogenesis: From Muscle Metabolism to Macrophage Polarization	0.0042796005706134095	3
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 13: Hyperglycemia-Induced Oxidative Stress and Inflammation in Diabetic COPD Comorbidity	0.0037735849056603774	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 11: Gut-Respiratory Axis: Inflammatory Disorders and Immune Dysregulation in COPD Pathogenesis	0.0037105751391465678	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 5: Environmental Toxicants and Cyclooxygenase Inhibition in Gastrointestinal COPD Pathways	0.003115264797507788	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 21: Neuroinflammatory Pathways in COPD: Intersection of Systemic Inflammation and Neurological Dysfunction	0.002894356005788712	2
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 37: Acute Lung Injury and Inflammatory Dysregulation as Precursors to COPD Progression and Exacerbation	0.0025575447570332483	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 33: Gut Microbiota Dysbiosis and Intestinal Immune Homeostasis Disruption in COPD Pathogenesis	0.0024630541871921183	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 10: Natural Bioactive Polyphenols and Flavonoids as Potential Therapeutic Agents in COPD Prevention	0.0020920502092050207	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 15: Sleep-Related Pathophysiology and Environmental Exposures in COPD Etiology and Progression	0.001953125	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 29: Racial and Socioeconomic Disparities in Ambient Air Pollution and COPD Burden	0.0011547344110854503	1
COPD Treatment Cluster 14: β Adrenergic Modulation for Managing Bladder Overactivity in COPD Patients	COPD Cause Cluster 36: Elucidating the Complex Genetic and Epithelial Mechanisms Underlying COPD Susceptibility and Progression	0.0009775171065493646	1
